Figure 2: Emodin inhibits HepG2 cell growth in the time- and dose-dependent manner. HepG2 cells were treated with increased concentrations of emodin for up to 72 hrs to examine the cell viability. The cell viability was determined using the CCK8 assay as described in Materials and Methods and was expressed as percentage of control in the mean ± SD of three separate experiments.